These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24900642)

  • 21. Development and Testing of Druglike Screening Libraries.
    Wang J; Ge Y; Xie XQ
    J Chem Inf Model; 2019 Jan; 59(1):53-65. PubMed ID: 30563329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HAMS: High-Affinity Mass Spectrometry Screening. A High-Throughput Screening Method for Identifying the Tightest-Binding Lead Compounds for Target Proteins with No False Positive Identifications.
    Imaduwage KP; Go EP; Zhu Z; Desaire H
    J Am Soc Mass Spectrom; 2016 Nov; 27(11):1870-1877. PubMed ID: 27600575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the prediction of statistical parameters in high-throughput screening using resampling techniques.
    Ilouga PE; Hesterkamp T
    J Biomol Screen; 2012 Jul; 17(6):705-12. PubMed ID: 22460175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence spectroscopic profiling of compound libraries.
    Simeonov A; Jadhav A; Thomas CJ; Wang Y; Huang R; Southall NT; Shinn P; Smith J; Austin CP; Auld DS; Inglese J
    J Med Chem; 2008 Apr; 51(8):2363-71. PubMed ID: 18363325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.
    Jenkins JL; Kao RY; Shapiro R
    Proteins; 2003 Jan; 50(1):81-93. PubMed ID: 12471601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. False positives in the early stages of drug discovery.
    Sink R; Gobec S; Pečar S; Zega A
    Curr Med Chem; 2010; 17(34):4231-55. PubMed ID: 20939815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a High Throughput Screen for the Identification of Inhibitors of Peptidoglycan
    Brott AS; Jones CS; Clarke AJ
    Antibiotics (Basel); 2019 May; 8(2):. PubMed ID: 31137799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative High-Throughput Screening Using a Coincidence Reporter Biocircuit.
    Schuck BW; MacArthur R; Inglese J
    Curr Protoc Neurosci; 2017 Apr; 79():5.32.1-5.32.27. PubMed ID: 28398644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of Titration-Based Screening for the Rapid Pilot Testing of High-Throughput Assays.
    Zhang JH; Kang ZB; Ardayfio O; Ho PI; Smith T; Wallace I; Bowes S; Hill WA; Auld DS
    J Biomol Screen; 2014 Jun; 19(5):651-60. PubMed ID: 24246376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
    Goldman RC
    Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors.
    Ferreira RS; Simeonov A; Jadhav A; Eidam O; Mott BT; Keiser MJ; McKerrow JH; Maloney DJ; Irwin JJ; Shoichet BK
    J Med Chem; 2010 Jul; 53(13):4891-905. PubMed ID: 20540517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays.
    Zhang XD
    J Biomol Screen; 2007 Aug; 12(5):645-55. PubMed ID: 17517904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Compounds That Interfere with High-Throughput Screening Assay Technologies.
    David L; Walsh J; Sturm N; Feierberg I; Nissink JWM; Chen H; Bajorath J; Engkvist O
    ChemMedChem; 2019 Oct; 14(20):1795-1802. PubMed ID: 31479198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Small-Molecule Frequent Hitters of Glutathione S-Transferase-Glutathione Interaction.
    Brenke JK; Salmina ES; Ringelstetter L; Dornauer S; Kuzikov M; Rothenaigner I; Schorpp K; Giehler F; Gopalakrishnan J; Kieser A; Gul S; Tetko IV; Hadian K
    J Biomol Screen; 2016 Jul; 21(6):596-607. PubMed ID: 27044684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luciferase Advisor: High-Accuracy Model To Flag False Positive Hits in Luciferase HTS Assays.
    Ghosh D; Koch U; Hadian K; Sattler M; Tetko IV
    J Chem Inf Model; 2018 May; 58(5):933-942. PubMed ID: 29667823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.
    Inglese J; Auld DS; Jadhav A; Johnson RL; Simeonov A; Yasgar A; Zheng W; Austin CP
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11473-8. PubMed ID: 16864780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors.
    Waack U; Johnson TL; Chedid K; Xi C; Simmons LA; Mobley HLT; Sandkvist M
    Front Cell Infect Microbiol; 2017; 7():380. PubMed ID: 28894700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosensor-based small molecule fragment screening with biolayer interferometry.
    Wartchow CA; Podlaski F; Li S; Rowan K; Zhang X; Mark D; Huang KS
    J Comput Aided Mol Des; 2011 Jul; 25(7):669-76. PubMed ID: 21660516
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.